Instruction to Authors

Neuroscience Bulletin is devoted to the publication of original contributions on any aspects of neuroscience research. Beside original Research papers, it publishes Communications, Experimental Methods, Review and Progress articles. Most reviews will be by invitation. However, suggestions for reviews are appreciated. Paper in English is acceptable.     

Instruction to Authors

Neuroscience Bulletin is devoted to the publication of original contributions on any aspects of neuroscience research. Beside original Research papers,it publishes Communications,Experimental Methods,Review and Progress articles. Most reviews will be by invitation.However,suggestions for reviews are appreciated.Paper in English is acceptable.     

Instruction to Authors

Neuroscience Bulletin is devoted to the publication of original contributions on any aspects of neuroscience research. Beside original Research papers, it publishes Communications,Experimental Methods, Review and Progress articles.     

Instructions to Authors

ＭａｎｕｓｃｒｉｐｔｓｕｂｍｉｓｓｉｏｎＣｈｉｎｅｓｅＪｏｕｒｎａｌｏｆＮｅｕｒｏｓｃｉｅｎｃｅ (ＣＪＮ)ｉｓｄｅｖｏｔｅｄｔｏｔｈｅｐｕｂｌｉｃａｔｉｏｎｏｆｏｒｉｇｉｎａｌｃｏｎｔｒｉｂｕｔｉｏｎｓｏｎａｎｙａｓｐｅｃｔｓｏｆｎｅｕｒｏｓｃｉｅｎｃｅｒｅｓｅａｒｃｈ .ＢｅｓｉｄｅＯｒｉｇｉｎａｌｒｅｓｅａｒｃｈｐａｐｅｒｓ,ｉｔｐｕｂｌｉｓｈｅｓＣｏｍｍｕｎｉｃａｔｉｏｎｓ,Ｅｘｐｅｒｉｍｅｎ ｔａｌｍｅｔｈｏｄｓ,ＲｅｖｉｅｗａｎｄＰｒｏｇｒｅｓｓａｒｔｉｃｌｅｓ.Ｍｏｓｔｒｅｖｉｅｗｓｗｉｌｌ…     

Instruction to Authors

General Information Neural Regeneration Research (NRR, ISSN 1673-5374) is an open access, peer-reviewed international     

Instruction to Authors

General Information Neural Regeneration Research (NRR, ISSN 1673-5374) is an open access, peer-reviewed international journal focusing exclusively on the exciting field of neural regeneration research, published 36 issues per year. NRR aims to timely publish innovative and creative basic     

Teaching students with developmental disabilities to operate an iPod Touch(®) to listen to music

We evaluated an intervention procedure for teaching three students with developmental disabilities to independently operate a portable multimedia device (i.e., an iPod Touch(?)) to listen to music. The intervention procedure included the use of video modeling, which was presented on the same iPod Touch(?) that the students were taught to operate to listen to music. Four phases (i.e., baseline, intervention, fading, and follow-up) were arranged in accordance with a delayed multiple-probe across participants design. During baseline, the students performed from 25 to 62.5% of the task analyzed steps correctly. With intervention, all three students correctly performed 80-100% of the steps and maintained this level of performance when video modeling was removed and during follow-up. The findings suggest that the video modeling procedure was effective for teaching the students to independently operate a portable multimedia device to access age-appropriate leisure content.     

Neonatal seizures: to treat or not to treat?

The immature brain is intrinsically hyperexcitable, a feature that, despite being crucial for learning, synaptogenesis and neuronal plasticity, predisposes the neonate to seizures. Seizures represent the most common neurologic manifestation of impaired brain function in this age group. Importantly, although seizure-induced neuronal injury is minimal in the "healthy" neonatal brain, the "metabolically-compromised" brain appears more vulnerable. Even in the "healthy" brain, however, seizures result in impaired learning, enhanced susceptibility to further seizures, and increased risk of brain injury with seizures later in life, as a result of altered hippocampal circuitry. Given these findings, an aggressive approach to neonatal seizures appears warranted. However, our current conventional therapies (including phenobarbital, phenytoin, and benzodiazepines), even when used in combination, are often ineffective in controlling seizures. Lidocaine may yield better efficacy but requires more study. Recent animal data suggest that alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) antagonists such as topiramate may have a neuroprotective role. However, further work is needed to confirm the safety of excitatory amino acid antagonists in neonates because there remains a prevailing concern that such agents may impair normal neurodevelopmental processes.